Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 2
2013 3
2017 3
2018 1
2019 4
2020 4
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies.
Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S; PROBAST Group†. Wolff RF, et al. Ann Intern Med. 2019 Jan 1;170(1):51-58. doi: 10.7326/M18-1376. Ann Intern Med. 2019. PMID: 30596875 Free article.
PROBAST (Prediction model Risk Of Bias ASsessment Tool), a tool for assessing the risk of bias (ROB) and applicability of diagnostic and prognostic prediction model studies, was developed by a steering group that considered existing ROB tools and reporting guideline …
PROBAST (Prediction model Risk Of Bias ASsessment Tool), a tool for assessing the risk of bias (ROB) and applicability of diagnostic …
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis.
Swift SL, Puehler T, Misso K, Lang SH, Forbes C, Kleijnen J, Danner M, Kuhn C, Haneya A, Seoudy H, Cremer J, Frey N, Lutter G, Wolff R, Scheibler F, Wehkamp K, Frank D. Swift SL, et al. BMJ Open. 2021 Dec 6;11(12):e054222. doi: 10.1136/bmjopen-2021-054222. BMJ Open. 2021. PMID: 34873012 Free PMC article.
DATA EXTRACTION AND SYNTHESIS: Two independent reviewers were involved in data extraction and risk of bias (ROB) assessment using the Cochrane tool (one reviewer extracted/assessed the data, and the second reviewer checked it). ...Subgroup analysis generally favoured TAVI …
DATA EXTRACTION AND SYNTHESIS: Two independent reviewers were involved in data extraction and risk of bias (ROB) assessment using the …
Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Otten T, Riemsma R, Wijnen B, Armstrong N, Stirk L, Gordon C, Ramaekers B, Kleijnen J, Joore M, Grimm S. Otten T, et al. Pharmacoeconomics. 2022 Sep;40(9):851-861. doi: 10.1007/s40273-022-01166-2. Epub 2022 Jul 8. Pharmacoeconomics. 2022. PMID: 35802295 Free PMC article. Review.
As part of its Single Technology Appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer (GlaxoSmithKline [GSK]) of Benlysta (belimumab) to submit evidence regarding its clinical and cost effectiveness, for the review and pos …
As part of its Single Technology Appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufactu …
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pouwels XGLV, Petersohn S, Carrera VH, Denniston AK, Chalker A, Raatz H, Armstrong N, Shah D, Witlox W, Worthy G, Noake C, Riemsma R, Kleijnen J, Joore MA. Pouwels XGLV, et al. Pharmacoeconomics. 2020 May;38(5):431-441. doi: 10.1007/s40273-019-00851-z. Pharmacoeconomics. 2020. PMID: 31701471 Free PMC article. Review.
The National Institute for Health and Care Excellence (NICE) invited Alimera Sciences, the company manufacturing fluocinolone acetonide intravitreal implant (FAc) 0.19 mg (tradename ILUVIEN()), to submit evidence on the clinical and cost-effectiveness of FAc for treating recurren …
The National Institute for Health and Care Excellence (NICE) invited Alimera Sciences, the company manufacturing fluocinolone acetonide intr …
Electro-coagulation for liver metastases.
Riemsma RP, Bala MM, Wolff R, Kleijnen J. Riemsma RP, et al. Cochrane Database Syst Rev. 2013 May 31;(5):CD009497. doi: 10.1002/14651858.CD009497.pub2. Cochrane Database Syst Rev. 2013. PMID: 23728692 Updated. Review.
EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties.
Dickson R, Boland A, Duarte R, Kotas E, Woolacott N, Hodgson R, Riemsma R, Grimm S, Ramaekers B, Joore M, Büyükkaramikli N, Kaltenthaler E, Stevenson M, Pandor A, Edwards S, Hoyle M, Shepherd J, Armoiry X, Brazzelli M. Dickson R, et al. Appl Health Econ Health Policy. 2018 Aug;16(4):429-432. doi: 10.1007/s40258-018-0393-7. Appl Health Econ Health Policy. 2018. PMID: 29808296 Free PMC article. No abstract available.
Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Büyükkaramikli NC, Blommestein HM, Riemsma R, Armstrong N, Clay FJ, Ross J, Worthy G, Severens J, Kleijnen J, Al MJ. Büyükkaramikli NC, et al. Pharmacoeconomics. 2017 Dec;35(12):1211-1221. doi: 10.1007/s40273-017-0528-y. Pharmacoeconomics. 2017. PMID: 28656543 Free PMC article. Review.
The National Institute for Health and Care Excellence (NICE) invited the company that manufactures ramucirumab (Cyramza(), Eli Lilly and Company) to submit evidence of the clinical and cost effectiveness of the drug administered alone (monotherapy) or with paclitaxel (combination …
The National Institute for Health and Care Excellence (NICE) invited the company that manufactures ramucirumab (Cyramza(), Eli Lilly and Com …
Can incontinence be cured? A systematic review of cure rates.
Riemsma R, Hagen S, Kirschner-Hermanns R, Norton C, Wijk H, Andersson KE, Chapple C, Spinks J, Wagg A, Hutt E, Misso K, Deshpande S, Kleijnen J, Milsom I. Riemsma R, et al. BMC Med. 2017 Mar 24;15(1):63. doi: 10.1186/s12916-017-0828-2. BMC Med. 2017. PMID: 28335792 Free PMC article. Review.
Digital interventions to moderate physical inactivity and/or nutrition in young people: a Cancer Prevention Europe overview of systematic reviews.
McDermott KT, Noake C, Wolff R, Bauld L, Espina C, Foucaud J, Steindorf K, Thorat MA, Weijenberg MP, Schüz J, Kleijnen J. McDermott KT, et al. Front Digit Health. 2023 Jul 4;5:1185586. doi: 10.3389/fdgth.2023.1185586. eCollection 2023. Front Digit Health. 2023. PMID: 37534029 Free PMC article. Review.
Records were independently screened by title and abstract by two reviewers and those deemed eligible were obtained for full text screening. Risk of bias (RoB) was assessed with the Risk of Bias Assessment Tool for Systematic Reviews (ROBIS) tool. ...Smartphone based interv …
Records were independently screened by title and abstract by two reviewers and those deemed eligible were obtained for full text screening. …
Systematic review of tapentadol in chronic severe pain.
Riemsma R, Forbes C, Harker J, Worthy G, Misso K, Schäfer M, Kleijnen J, Stürzebecher S. Riemsma R, et al. Curr Med Res Opin. 2011 Oct;27(10):1907-30. doi: 10.1185/03007995.2011.611494. Epub 2011 Sep 12. Curr Med Res Opin. 2011. PMID: 21905968 Review.
26 results